GABRG2 rs4532: Understanding This Common Genetic Variant
The rs4532 variant is a common genetic marker located within the GABRG2 gene, which provides instructions for building a critical component of the brain's inhibitory signaling system. Researchers study this variant to understand how subtle differences in GABA receptor function may influence individual susceptibility to seizure-related traits.
What each genotype means
Typical GABRG2 profile
This genotype represents the most common form of the GABRG2 gene in the general population. While GABRG2 is known to influence GABA receptor function and seizure thresholds, this specific genotype is not typically associated with the rare, pathogenic mutations linked to epilepsy syndromes. If you have concerns about seizure history or neurological health, please discuss them with your clinician.
This is the most common genotype observed across all major global populations.
Typical GABRG2 profile
This genotype is common and generally considered part of the normal range of genetic variation for the GABRG2 gene. Research into GABRG2 focuses primarily on rare, deleterious mutations that impair GABA receptor function, rather than this common variation. You should consult with a healthcare provider if you have specific questions regarding your neurological health or family history.
This genotype is frequently found in diverse populations worldwide.
Typical GABRG2 profile
This genotype is a standard variation of the GABRG2 gene found in the general population. Current scientific literature does not link this specific common genotype to an increased risk of epilepsy or seizure disorders. As with any genetic information, please consult a medical professional if you have questions about your health or potential symptoms.
This genotype is common and widely distributed across various ancestral groups.
What is the rs4532 Variant?
The rs4532 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that encodes the gamma-2 subunit of the GABA-A receptor. Because this gene is highly expressed in the central nervous system, researchers are interested in whether variations here might alter the structure or expression of these receptors. While many SNPs are neutral, scientists investigate rs4532 to determine if it contributes to the biological variability observed in how different people process inhibitory signals in the brain. It is important to note that rs4532 is a common variant, meaning it is frequently found in the general population and is not inherently a sign of a medical condition.
The Role of the GABRG2 Gene
The GABRG2 gene is essential for the proper function of GABA-A receptors, which are the primary inhibitory neurotransmitter receptors in the mammalian brain. These receptors act like a 'brake' for neuronal activity, helping to maintain a balance between excitation and inhibition. When GABA binds to these receptors, it allows chloride ions to enter neurons, which reduces the likelihood that the cell will fire an electrical signal. The gamma-2 subunit, encoded by GABRG2, is a crucial component that allows these receptors to cluster at the synapse and respond effectively to benzodiazepines and other modulators. Disruptions or significant mutations in this gene have been linked to various epilepsy syndromes, ranging from simple febrile seizures to severe developmental and epileptic encephalopathies. Understanding the normal function of this gene is key to interpreting how genetic variations might influence neurological health.
Research and Evidence Strength
The evidence linking rs4532 to specific clinical outcomes is currently considered moderate. While the GABRG2 gene itself is well-established as a major player in epilepsy genetics, the specific impact of the rs4532 variant is less clear. Many studies focus on rare, pathogenic mutations in GABRG2 that cause severe, early-onset epilepsy. In contrast, rs4532 is a common variant, and its association with seizure thresholds or other neurological traits is often studied in the context of complex, polygenic inheritance. This means that if rs4532 has any effect, it likely works in combination with many other genetic and environmental factors rather than acting as a single cause of disease. Current research does not support using this variant as a standalone diagnostic tool. Because the evidence is mixed and often dependent on specific population backgrounds, it remains a subject of ongoing scientific inquiry rather than clinical application.
What You Can Do With This Information
Genetic information like the rs4532 genotype is primarily for educational purposes and should not be used to make personal health decisions. Because this variant is common and its clinical significance is not fully defined, knowing your genotype does not provide a clear prediction of your health or risk for neurological conditions. If you have concerns about seizures, epilepsy, or your family medical history, the most important step is to consult with a qualified healthcare provider or a genetic counselor. They can evaluate your symptoms, medical history, and family background to provide appropriate guidance. Never change your medication or treatment plan based on genetic test results without first discussing it with your clinician or pharmacist. Genetic research is constantly evolving, and what is known about a specific SNP today may be refined by future studies.
How common is this variant?
The rs4532 variant is a common polymorphism, with its specific allele frequencies varying across different global ancestral populations as documented in large-scale genomic databases.
Frequently asked questions
Is rs4532 a cause of epilepsy?
No, rs4532 is a common genetic variant and is not considered a direct cause of epilepsy. While the GABRG2 gene is associated with various seizure disorders, those conditions are typically linked to rare, highly disruptive mutations, not common SNPs like rs4532.
Should I be worried if I have the rs4532 variant?
There is no reason for concern. Because rs4532 is a common variant found in a large portion of the healthy population, it is generally considered a normal part of human genetic diversity.
Can a DNA test tell me if I will have seizures?
No, a standard genetic test for common variants cannot predict whether you will develop seizures. Epilepsy is a complex condition influenced by many genetic and environmental factors, and common variants like rs4532 do not have enough predictive power for clinical diagnosis.
Where can I learn more about my GABRG2 gene?
You can find reliable information about the GABRG2 gene and its role in health through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI). Always discuss any specific health concerns with your doctor.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4532?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.